Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) today announced that it successfully completed the previously announced acquisition of...
View ArticleOsprey Medical Announces Oversubscribed A$28 Million Private Placement
MINNEAPOLIS & MELBOURNE, Australia Osprey Medical, Inc. (ASX:OSP) (Osprey or Company) today announces that it has received commitments from sophisticated and institutional investors to subscribe...
View ArticleAmpliPhi Biosciences Granted Japanese Patent Covering the Use of Phage...
SAN DIEGO AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today announced that...
View ArticleNCCNガイドラインでオプチューンが初発膠芽腫の標準的治療の選択肢として推奨される
ジャージー島セントへリア (ビジネスワイヤ) — ノボキュア社(NASDAQ: NVCR)は本日、全米総合がん情報ネットワーク(NCCN)が中枢神経系がんの腫瘍診療ガイドライン(NCCNガイドライン)で、オプチューンを初発膠芽腫(GBM)の標準的治療の選択肢として推奨したと発表しました。...
View ArticleMasimo宣布儿科O3™ 局部氧饱和度仪获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布,配置O3儿科传感器的O3™ 局部氧饱和度仪的儿科适应证获得CE标记。局部氧饱和度仪也被称为组织或脑氧饱和度仪,可帮助临床医生监测脑氧合状况。 Smart News Releases(智能新闻稿)是一个多媒体平台。在此处查看完整新闻稿:...
View Article昆泰与DaVita临床研究宣布缔结战略联盟
北卡罗莱纳州研究三角园区和明尼阿波利斯 (美国商业资讯) — 世界最大的产品开发和整合医疗保健服务提供商昆泰和肾脏医护领域的领先者DaVita HealthCare Partners Inc.的全资子公司DaVita临床研究(DaVita Clinical...
View Articleマシモが小児用O3™リージョナルオキシメトリーのCEマーク取得を発表
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、小児用O3センサーを備えたO3™リージョナルオキシメトリーの小児適応に対するCEマーク取得を発表しました。組織オキシメトリーまたは脳オキシメトリーとも呼ばれるリージョナルオキシメトリーは、臨床医が脳酸素化状態をモニタリングするのに役立ちます。 このSmart News...
View ArticleTakeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced Takeda Canada has received approval from Health Canada for NINLARO™ (ixazomib) capsules in...
View ArticleNichi-Iko Pharmaceutical Co., Ltd. Announces Expiration of HSR Waiting Period...
TOKYO Nichi-Iko Pharmaceutical Co., Ltd. (TSE: 4541) (“Nichi-Iko” or “Parent”) and Shepard Vision, Inc. (“Purchaser”) announced that the waiting period under the Hart-Scott-Rodino Antitrust...
View ArticleAcucela Announces Official Name of Acucela Japan as Kubota Pharmaceutical...
SEATTLE Acucela Inc. (Tokyo: 4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleAward-winning Journalist David O’Shea Joins This Year’s Experts at the 2016...
MADISON, Wis. The largest international conference on DNA analysis for human identification, the 27th International Symposium on Human Identification (ISHI) will feature presentations from leading...
View ArticlePhase I Clinical Trials Underway for First MERS Treatment
SIOUX FALLS, S.D. SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, announced today that Phase I Clinical Trials are underway for its human antibody treatment...
View ArticleOutcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent...
DUBLIN Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced the 12-month results of the 14 Presbia Flexivue Microlens™ surgeries performed on...
View ArticleCANbridge Signs Agreement with Boehringer Ingelheim to Manufacture Inhibitory...
SHANGHAI Boehringer Ingelheim and CANbridge Life Sciences announced that both parties have signed an agreement for the manufacture of CAN-017, an ErbB3 (HER3) inhibitory antibody to treat esophageal...
View ArticlePromega Maxwell® RSC Advances High Quality Sample Prep for Food Testing
MADISON, Wis. The launch of the Maxwell® RSC PureFood GMO* and Authentication Kit for food testing delivers automated high quality sample prep for food testing labs. The Maxwell RSC PureFood GMO and...
View ArticleDCAT Launches Networking Event in Barcelona to Serve Expanding Global Membership
ROBBINSVILLE, N.J. With over 40 percent of its new member companies headquartered outside North America, the Drug, Chemical & Associated Technologies Association (DCAT) is introducing a special...
View ArticlePromega 2016 Corporate Responsibility Report Highlights Initiatives...
MADISON, Wis. The latest publication of the Promega Corporate Responsibility Report focuses on the organization’s thoughtful growth through expansion of energy-efficient facilities, advances in...
View ArticleDCAT在巴塞罗那为不断壮大的全球会员群体举办交流活动
新泽西州罗宾斯维尔 (美国商业资讯)–药品、化学品与相关技术协会(DCAT)将于2016年10月5日(周三)晚间6:00到8:30在西班牙巴塞罗那Casa Llotja de Mar举办一场别开生面的交流活动。该协会超过40%的新企业会员都位于北美以外地区。交流会DCAT After The Show将在世界制药原料展览会(CPhI...
View ArticleDCAT、世界で拡大する会員に貢献するための交流イベントをバルセロナで創始
米ニュージャージー州ロビンズビル (ビジネスワイヤ) — 新規会員企業の40パーセント以上が本社を北米以外に置いているため、医薬品・化学製品・関連技術協会(DCAT)は、スペイン・バルセロナのCasa Llotja de...
View Article